Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX - New York Stock Exchange, Inc. - US4576511079 - Common Stock - Currency: USD

15.97  +0.05 (+0.31%)

After market: 15.97 0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to INVX. INVX was compared to 63 industry peers in the Energy Equipment & Services industry. INVX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. INVX is not overvalued while it is showing excellent growth. This is an interesting combination. This makes INVX very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

INVX had positive earnings in the past year.
INVX had a positive operating cash flow in the past year.
In multiple years INVX reported negative net income over the last 5 years.
In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

INVX has a Return On Assets of 12.97%. This is amongst the best in the industry. INVX outperforms 95.24% of its industry peers.
INVX has a better Return On Equity (15.85%) than 80.95% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.11%, INVX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA 12.97%
ROE 15.85%
ROIC 9.11%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

INVX has a better Profit Margin (17.21%) than 95.24% of its industry peers.
INVX's Profit Margin has improved in the last couple of years.
INVX has a better Operating Margin (13.44%) than 68.25% of its industry peers.
INVX's Operating Margin has improved in the last couple of years.
INVX has a better Gross Margin (34.30%) than 69.84% of its industry peers.
INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.44%
PM (TTM) 17.21%
GM 34.3%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INVX is destroying value.
Compared to 1 year ago, INVX has more shares outstanding
Compared to 5 years ago, INVX has more shares outstanding
The debt/assets ratio for INVX is higher compared to a year ago.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

INVX has an Altman-Z score of 4.88. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of INVX (4.88) is better than 90.48% of its industry peers.
The Debt to FCF ratio of INVX is 0.22, which is an excellent value as it means it would take INVX, only 0.22 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.22, INVX belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
INVX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
INVX has a better Debt to Equity ratio (0.02) than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.22
Altman-Z 4.88
ROIC/WACC0.98
WACC9.34%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 4.34 indicates that INVX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.34, INVX belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
INVX has a Quick Ratio of 2.49. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
INVX has a Quick ratio of 2.49. This is amongst the best in the industry. INVX outperforms 87.30% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 2.49
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

9

3. Growth

3.1 Past

INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 169.74%, which is quite impressive.
The Earnings Per Share has been growing by 123.23% on average over the past years. This is a very strong growth
INVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 103.21%.
INVX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.76% yearly.
EPS 1Y (TTM)169.74%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%140.32%
Revenue 1Y (TTM)103.21%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%117.98%

3.2 Future

The Earnings Per Share is expected to grow by 143.45% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 38.17% on average over the next years. This is a very strong growth
EPS Next Y450.7%
EPS Next 2Y143.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year89.37%
Revenue Next 2Y38.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

INVX is valuated quite expensively with a Price/Earnings ratio of 30.13.
63.49% of the companies in the same industry are cheaper than INVX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.45. INVX is around the same levels.
The Price/Forward Earnings ratio is 11.96, which indicates a very decent valuation of INVX.
INVX's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, INVX is valued a bit cheaper.
Industry RankSector Rank
PE 30.13
Fwd PE 11.96
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

INVX's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INVX indicates a somewhat cheap valuation: INVX is cheaper than 65.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.77
EV/EBITDA 6.54
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVX has a very decent profitability rating, which may justify a higher PE ratio.
INVX's earnings are expected to grow with 143.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)0.24
EPS Next 2Y143.45%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVEX INTERNATIONAL INC

NYSE:INVX (7/3/2025, 7:38:08 PM)

After market: 15.97 0 (0%)

15.97

+0.05 (+0.31%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner Change4.59%
Ins Owners1.52%
Ins Owner Change6.6%
Market Cap1.10B
Analysts45.71
Price Target17.34 (8.58%)
Short Float %N/A
Short Ratio6.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP48.35%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.25%
Min EPS beat(2)-22.68%
Max EPS beat(2)49.19%
EPS beat(4)1
Avg EPS beat(4)-48.57%
Min EPS beat(4)-165.36%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-180.4%
EPS beat(12)3
Avg EPS beat(12)-83.27%
EPS beat(16)3
Avg EPS beat(16)-116.41%
Revenue beat(2)2
Avg Revenue beat(2)8.68%
Min Revenue beat(2)7.14%
Max Revenue beat(2)10.21%
Revenue beat(4)3
Avg Revenue beat(4)6.28%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)10.25%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.25%
PT rev (3m)6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-17.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.56%
Revenue NQ rev (1m)2.68%
Revenue NQ rev (3m)2.68%
Revenue NY rev (1m)-10.45%
Revenue NY rev (3m)74.08%
Valuation
Industry RankSector Rank
PE 30.13
Fwd PE 11.96
P/S 1.22
P/FCF 9.77
P/OCF 8.56
P/B 1.13
P/tB 1.38
EV/EBITDA 6.54
EPS(TTM)0.53
EY3.32%
EPS(NY)1.34
Fwd EY8.36%
FCF(TTM)1.63
FCFY10.23%
OCF(TTM)1.86
OCFY11.68%
SpS13.06
BVpS14.18
TBVpS11.57
PEG (NY)0.07
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA 12.97%
ROE 15.85%
ROCE 11.53%
ROIC 9.11%
ROICexc 9.74%
ROICexgc 11.93%
OM 13.44%
PM (TTM) 17.21%
GM 34.3%
FCFM 12.51%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.22
Debt/EBITDA 0.12
Cap/Depr 39.09%
Cap/Sales 1.76%
Interest Coverage 250
Cash Conversion 79.51%
Profit Quality 72.7%
Current Ratio 4.34
Quick Ratio 2.49
Altman-Z 4.88
F-Score5
WACC9.34%
ROIC/WACC0.98
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)169.74%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%140.32%
EPS Next Y450.7%
EPS Next 2Y143.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)103.21%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%117.98%
Revenue Next Year89.37%
Revenue Next 2Y38.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9153.17%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year-16.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y211.64%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y263.32%
OCF growth 3Y34.47%
OCF growth 5Y44.76%